Evidence map›Paper›PMID 37509301›Full record

ArticleCancers2023

Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIV.

Lauren Greenberg, Lene Ryom, Elzbieta Bakowska, Ferdinand Wit, Heiner C Bucher, Dominique L Braun, Andrew Phillips, Caroline Sabin, Antonella d'Arminio Monforte, Robert Zangerle and 32 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Review
  7. Trends in Mortality in People With HIV From 1999 through 2020: A Multicohort Collaboration.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  8. Cancer in People with HIV.Infectious disease clinics of North America · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors at 20 institutions in 15 countries.

Lauren GreenbergCHIP, Centre of Excellence for Health, Immunity and Infections Rigshospitalet, University of Copenhagen, DK-2100 Copenhagen, Denmark.
Lene RyomCHIP, Centre of Excellence for Health, Immunity and Infections Rigshospitalet, University of Copenhagen, DK-2100 Copenhagen, Denmark.
Elzbieta BakowskaWojewódzki Szpital Zakaźny, 01-201 Warsaw, Poland.
Ferdinand WitStichting HIV Monitoring, 1105 BD Amsterdam, The Netherlands.
Heiner C BucherDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, 8001 Zurich, Switzerland.
Dominique L BraunDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, 8001 Zurich, Switzerland.ORCID 0000-0003-4036-1030
Andrew PhillipsCentre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London NW3 2PF, UK.
Caroline SabinCentre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London NW3 2PF, UK.
Antonella d'Arminio MonforteItalian Cohort Naive Antiretrovirals (ICONA), ASST Santi Paolo e Carlo, 20142 Milano, Italy.ORCID 0000-0003-0073-1789
Robert ZangerleAustrian HIV Cohort Study (AHIVCOS), Medizinische Universität Innsbruck, 6020 Innsbruch, Austria.ORCID 0000-0002-5375-7299
Colette SmithThe Royal Free HIV Cohort Study, Royal Free Hospital, University College London, London NW3 2PF, UK.
Stéphane De WitCHU Saint-Pierre, Centre de Recherche en Maladies Infectieuses a.s.b.l., 1000 Brussels, Belgium.
Fabrice BonnetCHU de Bordeaux and Bordeaux University, BPH, INSERM U1219, 33076 Bordeaux, France.
Christian PradierNice HIV Cohort, Université Côte d'Azur et Centre Hospitalier Universitaire, 06000 Nice, France.
Cristina MussiniModena HIV Cohort, Università Degli Studi Di Modena and Reggio Emilia, 41125 Modena, Italy.
Camilla MucciniSan Raffaele Scientific Institute, Università Vita-Salute San Raffaele, 20132 Milano, Italy.ORCID 0000-0002-0900-5639
Jörg J VehreschildUniversity Hospital Cologne, 50937 Cologne, Germany.
Jennifer HoyDepartment of Infectious Diseases, Alfred Hospital and Monash University, Melbourne 3004, Australia.ORCID 0000-0002-6948-7086
Veronica SvedhemSwedish InfCareHIV Cohort, Karolinska University Hospital, 141 86 Stockholm, Sweden.
Jose M MiróInfectious Diseases Service, Hospital Clinic-IDIBAPS, University of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0001-8057-7755
Jan-Christian WasmuthUniversity Hospital Bonn, 53127 Bonn, Germany.
Peter ReissAmsterdam UMC Location, Department of Global Health, University of Amsterdam, Global Health, Meibergdreef 9, 1105 Amsterdam, The Netherlands.ORCID 0000-0001-7896-6428
Josep M LlibreDepartment of Infectious Diseases, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.ORCID 0000-0002-7158-6753
Nikoloz ChkhartishviliGeorgian National AIDS Health Information System (AIDS HIS), Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia.
Christoph StephanHIV Center, University Hospital Frankfurt, Goethe-University, 60596 Frankfurt, Germany.ORCID 0000-0003-3777-9006
Camilla I HatlebergCHIP, Centre of Excellence for Health, Immunity and Infections Rigshospitalet, University of Copenhagen, DK-2100 Copenhagen, Denmark.
Bastian NeesgaardCHIP, Centre of Excellence for Health, Immunity and Infections Rigshospitalet, University of Copenhagen, DK-2100 Copenhagen, Denmark.
Lars PetersCHIP, Centre of Excellence for Health, Immunity and Infections Rigshospitalet, University of Copenhagen, DK-2100 Copenhagen, Denmark.
Nadine JaschinskiCHIP, Centre of Excellence for Health, Immunity and Infections Rigshospitalet, University of Copenhagen, DK-2100 Copenhagen, Denmark.ORCID 0000-0003-4847-2966
Nikos DedesEuropean AIDS Treatment Group, 1000 Brussels, Belgium.
Elena KuzovatovaNizhny Novgorod Scientific and Research Institute, 603155 Nizhny Novgorod, Russia.
Marc Van Der ValkStichting HIV Monitoring, 1105 BD Amsterdam, The Netherlands.
Marianna MenozziModena HIV Cohort, Università Degli Studi Di Modena and Reggio Emilia, 41125 Modena, Italy.
Clara LehmannUniversity Hospital Cologne, 50937 Cologne, Germany.
Kathy PetoumenosDepartment of Infectious Diseases, Alfred Hospital and Monash University, Melbourne 3004, Australia.
Harmony GargesViiV Healthcare, Research Triangle Park, Durham, NC 27709, USA.
Jim RooneyGilead Science, Foster City, CA 94404, USA.
Lital YoungMerck Sharp & Dohme, Rahway, NJ 07065, USA.
Jens D LundgrenCHIP, Centre of Excellence for Health, Immunity and Infections Rigshospitalet, University of Copenhagen, DK-2100 Copenhagen, Denmark.
Loveleen Bansi-MatharuCentre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London NW3 2PF, UK.
Amanda MocroftCHIP, Centre of Excellence for Health, Immunity and Infections Rigshospitalet, University of Copenhagen, DK-2100 Copenhagen, Denmark.
On Behalf Of The Respond And D A D Study Groups
University of Copenhagen · DKUniversity College London · GBStichting HIV Monitoring · NLUniversity Hospital Cologne · DEUniversity of Modena and Reggio Emilia · ITUniversity of Zurich · CHUNSW Sydney · AUAIDS and Clinical Immunology Research Center · GEAmsterdam Institute for Global Health and Development · NLAzienda Socio Sanitaria Territoriale Santi Paolo e CarloCentre Hospitalier Universitaire de Saint-Pierre · BEGilead Sciences (United States) · USGoethe University Frankfurt · DEHospital Universitari Germans Trias i Pujol · ESInnsbruck Medical University · ATInserm · FRInstituto de Salud Carlos III · ESKarolinska University Hospital · SEMerck & Co., Inc., Rahway, NJ, USA (United States) · USThe Royal Free Hospital · GB

Funding

Danish National Research Foundation DNRF126Gilead Sciences (United States) CO-EU-311-4339MSD (United States) LKR196747Please see manuscript for full funding details NAViiV Healthcare (United Kingdom) 207709
6 · The paper itself

Abstract

Despite cancer being a leading comorbidity amongst individuals with HIV, there are limited data assessing cancer trends across different antiretroviral therapy (ART)-eras. We calculated age-standardised cancer incidence rates (IRs) from 2006-2021 in two international cohort collaborations (D:A:D and RESPOND). Poisson regression was used to assess temporal trends, adjusted for potential confounders. Amongst 64,937 individuals (31% ART-naïve at baseline) and 490,376 total person-years of follow-up (PYFU), there were 3763 incident cancers (IR 7.7/1000 PYFU [95% CI 7.4, 7.9]): 950 AIDS-defining cancers (ADCs), 2813 non-ADCs, 1677 infection-related cancers, 1372 smoking-related cancers, and 719 BMI-related cancers (groups were not mutually exclusive). Age-standardised IRs for overall cancer remained fairly constant over time (8.22/1000 PYFU [7.52, 8.97] in 2006-2007, 7.54 [6.59, 8.59] in 2020-2021). The incidence of ADCs (3.23 [2.79, 3.72], 0.99 [0.67, 1.42]) and infection-related cancers (4.83 [4.2, 5.41], 2.43 [1.90, 3.05]) decreased over time, whilst the incidence of non-ADCs (4.99 [4.44, 5.58], 6.55 [5.67, 7.53]), smoking-related cancers (2.38 [2.01, 2.79], 3.25 [2.63-3.96]), and BMI-related cancers (1.07 [0.83, 1.37], 1.88 [1.42, 2.44]) increased. Trends were similar after adjusting for demographics, comorbidities, HIV-related factors, and ART use. These results highlight the need for better prevention strategies to reduce the incidence of NADCs, smoking-, and BMI-related cancers.

Indexed as

AIDS defining cancerbody mass indexHIVincidenceinfectionnon-AIDS defining cancersmokingtrends

Identifiers

PMID37509301
PMCPMC10377704
OpenAlexW4384525546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.